Buscar
Mostrando ítems 31-40 de 335
Relación de las estrategias de afrontamiento con la calidad de vida en los pacientes con Nefritis Lúpica Barranquilla-Colombia, 2018
(Ediciones Universidad Simón BolívarFacultad de Ciencias de la Salud, 2019)
Introducción: El lupus eritematoso sistémico (LES) es una enfermedad autoinmune, crónica, inflamatoria, que tiene manifestaciones clínicas muy diversas que afectan la función de distintos órganos y sistemas del cuerpo. La ...
Explorando el poder de los abordajes transcriptómicos para identificar biomarcadores asociados a daño renal en pacientes con lupus eritematoso sistémico
(Asociación Colombiana de Nefrología e hipertensión ArterialFacultad de Ciencias de la Salud, 2021-02-02)
El lupus eritematoso sistémico (LES) es una enfermedad compleja y altamente heterogénea que
afecta múltiples órganos, incluyendo articulaciones, corazón, sistema hematopoyético, sistema
nervioso y riñón, siendo este ...
First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatology (PANLAR)
(BMJ Publishing Group, 2018)
Systemic lupus erythematosus (SLE), a complex and heterogeneous autoimmune disease, represents a significant challenge for both diagnosis and treatment. Patients with SLE in Latin America face special problems that should ...
Monocyte Chemoattractant-1 as a Urinary Biomarker for the Diagnosis of Activity of Lupus Nephritis in Brazilian Patients
(J RHEUMATOL PUBL COTORONTO, 2012)
Objective. Monocyte chemotactic protein (MCP-1), involved in the pathogenesis of lupus nephritis (LN), has recently been indicated as a new biomarker of kidney activity in systemic lupus erythematosus (SLE). Our aim was ...
First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatology (PAN
(BMJ Publishing Group, 2018)
© Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. Systemic lupus erythematosus (SLE), a complex and heterogeneous autoimmune ...
Estudio del polimorfismo de receptores FcgammaIIa en pacientes chilenos con lupus eritematoso sistémico
(Sociedad Médica de Santiago, 2003)
Association of the MCP-1-2518 A/G Polymorphism and No Association of Its Receptor CCR2-64 V/I Polymorphism with Lupus Nephritis
(J RHEUMATOL PUBL CO, 2010)
Objective. To evaluate whether the A/G polymorphism at position 2518 in the regulatory region of the monocyte chemoattractant protein-1 (MCP-1) or the V/I polymorphism at position 64 of the receptor. CCR2, are associated ...
Determination of Cyclophosphamide Enantiomers in Plasma by LC-MS/MS: Application to Pharmacokinetics in Breast Cancer and Lupus Nephritis Patients
(WILEY-LISS, 2009)
This article describes the enantioseleclive analysis of cyclophosphamide (CPA) in human plasma using LC-MS/MS. CPA enantiomers were extracted from plasma using a mixture of ethyl acetate and chloroform (75:25, v/v). The ...
Influence of Glomerular Filtration Rate on the Pharmacokinetics of Cyclophosphamide Enantiomers in Patients With Lupus Nephritis
(SAGE PUBLICATIONS INC, 2009)
The pharmacokinetics of cyclophosphamide (CYC) enantiomers were evaluated in patients with lupus nephritis distributed in 2 groups according to creatinine clearance: group 1 (90.6-144.6 mL/min/1.73 m(2)) and group 2 ...
DECREASED PLATELET COUNTS AND DECREASED PLATELET SEROTONIN IN POSTSTREPTOCOCCAL NEPHRITIS
(KARGER, 1995)
Mean platelet survival time in patients with acute poststreptococcal glomerulo-nephritis (APSGN) is reduced to 50-60% of the control values, and glomerular deposits of platelet factor 4 are found in these patients. In order ...